Latest News and Press Releases
Want to stay updated on the latest news?
-
Phase 3 open-label extension completed on schedule in patients with negative symptoms of schizophrenia and data will be available in H1 2021 Minerva’s royalty interest in seltorexant acquired by...
-
WALTHAM, Mass., March 01, 2021 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central...
-
All financial figures are in Canadian dollars unless otherwise noted CALGARY, Alberta, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Gibson Energy Inc. announced today its financial and operating results for...